Franceschi L.; Cojutti P.; Baraldo M.; Pea F., Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures, «THERAPEUTIC DRUG MONITORING», 2014, 36, pp. 674 - 676 [articolo]
Pea F.; Cojutti P.; Merelli M.; Crapis M.; Bassetti M., Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2014, 44, pp. 570 - 571 [articolo]
Cojutti P.; Candoni A.; Simeone E.; Franceschi L.; Fanin R.; Pea F., Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: Dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2013, 57, pp. 6081 - 6084 [articolo]
Matteo Bassetti;Elda Righi;Massimo Crapis;Piergiorgio Cojutti;Sergio Venturini;Pierluigi Viale;Federico Pea, Gentamicin once-daily in enterococcal endocarditis, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2013, 168, pp. 5033 - 5034 [articolo]
F. Pea;P. Viale;P. Cojutti;M. Furlanut, Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2012, 56, pp. 6343 - 6348 [articolo]
Pea F.; Cojutti P.; Dose L.; Furian C.; Guarrera G.; Furlanut M., Personalization of antimicrobial dosing regimens: Indicators of performance, «ITALIAN JOURNAL OF PUBLIC HEALTH», 2012, 9, pp. 1 - 5 [articolo]
Pea F; Cojutti P; Pagotto A; Cristini F; Furlanut M; Viale P, Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2012, 56, pp. 3438 - 3440 [articolo]
Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M, Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients., «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2012, 67, pp. 2034 - 2042 [articolo]
Pea, Federico; Cojutti, Piergiorgio; Petrosillo, Nicola; Furlanut, Mario; Entenza, J M; Veloso, T R; Vouillamoz, J; Giddey, M; Moreillon, P, Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2011, 55, pp. 4496 - 4497 [replica/breve intervento]
Pea F.; Cojutti P.; Sbrojavacca R.; Cadeo B.; Cristini F.; Bulfoni A.; Furlanut M., TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient, «THE ANNALS OF PHARMACOTHERAPY», 2011, 45, pp. e37 - 1022 [articolo]
Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P., Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2010, 54, pp. 4605 - 4610 [articolo]
Pea F.; Baccarani U.; Tavio M.; Cojutti P.; Adani G.L.; Londero A.; Baraldo M.; Franceschi L.; Furlanut M.; Viale P., Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient, «THE ANNALS OF PHARMACOTHERAPY», 2008, 42, pp. 1711 - 1716 [articolo]
